

Health Care: Drugs
King Pharmaceuticals Inc. (KG: NYSE)
$14.24 0.00 | 0.00%
02/28/11 - 04:03 PM ET
366.93K / 3.10M
Vol / Avg. Vol:
14.25 / 14.24
Open / Prev. Close:
14.24 - 14.25
Today's Range:
Portfolios with KG
Latest KG Headlines from TheStreet
More Financial News for KG
Press Releases for KG
- Klondike Gold Corp. Advances Consolidation Of Yukon Mining Interests - Business Wire 04.05.12 | 07:04 pm
- REMOXY® New Drug Application Accepted By The FDA With PDUFA Goal Date Of June 23, 2011 - PR Newswire 01.27.11 | 08:01 am
- REMOXY® New Drug Application Resubmitted - PR Newswire 12.27.10 | 07:12 am
- Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc. - PR Newswire 12.15.10 | 05:12 pm
- Pfizer Commences Tender Offer For All Outstanding Shares Of King Pharmaceuticals, Inc. - PR Newswire 10.22.10 | 08:10 am
- The Law Office Of Abe Shainberg Is Launching An Investigation Into The Possible Breaches Of Fiduciary Duty By The Board Of King Pharmaceuticals, Inc. In Connection With The Sale Of The Company To Pfizer, Inc. – KG - Business Wire 10.13.10 | 03:10 pm
- Levetown & Jenkins, LLP Announces An Investigation Of The Acquisition Of King Pharmaceuticals, Inc. By Pfizer, Inc. - Business Wire 10.12.10 | 11:10 pm
- Law Office Of Brodsky & Smith, LLC Announces Investigation Of King Pharmaceuticals - Business Wire 10.12.10 | 09:10 pm
- Finkelstein Thompson LLP Announces Investigation Of King Pharmaceuticals Inc. - Business Wire 10.12.10 | 09:10 pm
- Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of King Pharmaceuticals, Inc. - Business Wire 10.12.10 | 08:10 pm
See All Press Releases